Hipra’s Covid-19 booster gets EMA nod and enters an uncertain landscape
Pharmaceutical Technology
MARCH 31, 2023
Available to people ages 16 years and above who have been vaccinated with a Covid-19 mRNA vaccine, EMA’s Human Medicines Committee concluded the vaccine is ready for marketing authorization in the EU, on 30 March. Bimervax is a recombinant protein subunit vaccine, marketed by the Girona, Spain-based Hipra.
Let's personalize your content